Trial Profile
Application of Daptomycin in MRSA Infected Diabetic Foot in Comparison to Vancomycin Treatment.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 20 Mar 2024
Price :
$35
*
At a glance
- Drugs Daptomycin (Primary) ; Vancomycin
- Indications Diabetic foot ulcer; Methicillin-resistant Staphylococcus aureus infections
- Focus Therapeutic Use
- 12 May 2012 New source identified and integrated (European Clinical Trials Databases; EudraCT2010-022348-18).
- 26 Mar 2012 Actual patient number (1) added as reported by ClinicalTrials.gov.
- 26 Mar 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.